Tilray Brands, Inc. Financing Cash Flow
Tilray Brands, Inc. (TLRY) reported Financing Cash Flow of $130.99 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-07-28
- Tilray Brands, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-05-31 was $68.17M, a 309.65% increase year-over-year.
- Tilray Brands, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-02-28 was -$5.13M, a 128.38% decline year-over-year.
- Tilray Brands, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-11-30 was $48.10M, a 25.91% increase year-over-year.
- Tilray Brands, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-08-31 was $19.85M, a 67.24% decline year-over-year.
- Tilray Brands, Inc. net cash provided by (used in) financing activities for fiscal 2026 was $130.99M, a 1.88% decline from fiscal 2025.
- Tilray Brands, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $133.51M.
- Tilray Brands, Inc. net cash provided by (used in) financing activities for fiscal 2024 was -$75.19M, a 207.17% decline from fiscal 2023.
- Tilray Brands, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $70.16M, a 45.27% decline from fiscal 2022.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-05-31 | $68.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $63.05M derived: sum of 2 quarters · filed 2026-07-28 | $111.15M derived: sum of 3 quarters · filed 2026-07-28 | $130.99M 10-K · filed 2026-07-28 |
| 2026-02-28 | -$5.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-01 | $42.97M derived: sum of 2 quarters · filed 2026-04-01 | $62.82M 10-Q · filed 2026-04-01 | $79.46M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-11-30 | $48.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $67.95M 10-Q · filed 2026-01-08 | $84.59M derived: sum of 3 quarters · filed 2026-07-28 | $102.66M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-08-31 | $19.85M 10-Q · filed 2025-10-09 | $36.49M derived: sum of 2 quarters · filed 2026-07-28 | $54.56M derived: sum of 3 quarters · filed 2026-07-28 | $92.76M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-05-31 | $16.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $34.71M derived: sum of 2 quarters · filed 2026-07-28 | $72.92M derived: sum of 3 quarters · filed 2026-07-28 | $133.51M 10-K · filed 2026-07-28 |
| 2025-02-28 | $18.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-01 | $56.27M derived: sum of 2 quarters · filed 2026-04-01 | $116.86M 10-Q · filed 2026-04-01 | $123.93M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-11-30 | $38.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $98.79M 10-Q · filed 2026-01-08 | $105.86M derived: sum of 3 quarters · filed 2026-07-28 | $94.95M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-08-31 | $60.59M 10-Q · filed 2025-10-09 | $67.66M derived: sum of 2 quarters · filed 2026-07-28 | $56.75M derived: sum of 3 quarters · filed 2026-07-28 | -$28.61M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-05-31 | $7.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | -$3.84M derived: sum of 2 quarters · filed 2026-07-28 | -$89.20M derived: sum of 3 quarters · filed 2026-07-28 | -$75.19M 10-K · filed 2026-07-28 |
| 2024-02-29 | -$10.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-08 | -$96.28M derived: sum of 2 quarters · filed 2025-04-08 | -$82.26M 10-Q · filed 2025-04-08 | -$76.02M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-11-30 | -$85.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-10 | -$71.35M 10-Q · filed 2025-01-10 | -$65.11M derived: sum of 3 quarters · filed 2025-07-29 | -$67.55M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-08-31 | $14.02M 10-Q · filed 2024-10-10 | $20.25M derived: sum of 2 quarters · filed 2025-07-29 | $17.81M derived: sum of 3 quarters · filed 2025-07-29 | -$39.44M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-05-31 | $6.24M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | $3.79M derived: sum of 2 quarters · filed 2025-07-29 | -$53.46M derived: sum of 3 quarters · filed 2025-07-29 | $70.16M 10-K · filed 2025-07-29 |
| 2023-02-28 | -$2.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09 | -$59.70M derived: sum of 2 quarters · filed 2024-04-09 | $63.92M 10-Q · filed 2024-04-09 | $225.73M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-11-30 | -$57.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-09 | $66.36M 10-Q · filed 2024-01-09 | $228.17M derived: sum of 3 quarters · filed 2024-10-10 | $222.61M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-08-31 | $123.62M 10-Q · filed 2024-10-10 | $285.43M derived: sum of 2 quarters · filed 2024-10-10 | $279.86M derived: sum of 3 quarters · filed 2024-10-10 | $259.84M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-05-31 | $161.81M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $156.24M derived: sum of 2 quarters · filed 2024-07-30 | $136.22M derived: sum of 3 quarters · filed 2024-07-30 | $128.20M 10-K · filed 2024-07-30 |
| 2022-02-28 | -$5.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-10 | -$25.58M derived: sum of 2 quarters · filed 2023-04-10 | -$33.61M 10-Q · filed 2023-04-10 | -$96.49M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-11-30 | -$20.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | -$28.05M 10-Q · filed 2023-01-09 | -$90.92M derived: sum of 3 quarters · filed 2023-07-26 | |
| 2021-08-31 | -$8.03M 10-Q · filed 2022-10-07 | -$70.90M derived: sum of 2 quarters · filed 2023-07-26 | ||
| 2021-05-31 | -$62.88M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | $124.31M 10-K · filed 2023-07-26 | ||
| 2021-03-31 | $234.08M 10-Q · filed 2021-05-10 | |||
| 2021-02-28 | $81.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-06 | $187.18M 10-Q · filed 2022-04-06 | ||
| 2020-12-31 | $54.73M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $264.85M 10-K · filed 2021-02-19 | ||
| 2020-11-30 | $99.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-10 | $105.94M 10-Q · filed 2022-01-10 | ||
| 2020-09-30 | $44.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $210.12M 10-Q · filed 2020-11-09 | ||
| 2020-08-31 | $6.74M 10-Q · filed 2021-10-07 | |||
| 2020-06-30 | $5.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $165.21M 10-Q · filed 2020-08-10 | $234.81M derived: sum of 3 quarters · filed 2021-05-10 | $274.21M derived: sum of 4 quarters · filed 2021-05-10 |
| 2020-05-31 | $130.61M 10-K · filed 2022-07-28 | |||
| 2020-03-31 | $159.79M 10-Q · filed 2021-05-10 | $229.39M derived: sum of 2 quarters · filed 2021-05-10 | $268.78M derived: sum of 3 quarters · filed 2021-05-10 | $273.74M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $69.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $109.00M derived: sum of 2 quarters · filed 2021-02-19 | $113.96M derived: sum of 3 quarters · filed 2021-02-19 | $114.70M 10-K · filed 2021-02-19 |
| 2019-09-30 | $39.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $44.35M derived: sum of 2 quarters · filed 2020-11-09 | $45.10M 10-Q · filed 2020-11-09 | $496.43M derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-06-30 | $4.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $5.70M 10-Q · filed 2020-08-10 | $457.04M derived: sum of 3 quarters · filed 2021-02-19 | $580.67M derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-05-31 | $547.18M 10-K · filed 2021-07-28 | |||
| 2019-03-31 | $744.00K 10-Q · filed 2020-05-11 | $452.07M derived: sum of 2 quarters · filed 2021-02-19 | $575.71M derived: sum of 3 quarters · filed 2021-02-19 | $577.83M derived: sum of 4 quarters · filed 2021-02-19 |
| 2018-12-31 | $451.33M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $574.97M derived: sum of 2 quarters · filed 2021-02-19 | $577.09M derived: sum of 3 quarters · filed 2021-02-19 | $631.00M 10-K · filed 2021-02-19 |
| 2018-09-30 | $123.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $125.76M derived: sum of 2 quarters · filed 2019-11-13 | $179.67M 10-Q · filed 2019-11-13 | $187.03M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $2.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $56.03M 10-Q · filed 2019-08-13 | $63.39M derived: sum of 3 quarters · filed 2020-03-02 | $64.98M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $53.91M 10-Q · filed 2019-05-15 | $61.27M derived: sum of 2 quarters · filed 2020-03-02 | $62.87M derived: sum of 3 quarters · filed 2020-03-02 | |
| 2017-12-31 | $7.36M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $8.96M derived: sum of 2 quarters · filed 2020-03-02 | $12.23M 10-K · filed 2020-03-02 | |
| 2017-09-30 | $1.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $4.87M 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | $3.28M 10-Q · filed 2018-08-29 | |||
| 2016-12-31 | $10.92M 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |